Time for newer approach in age-old AIHA: Daratumumab?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time for newer approach in age-old AIHA: Daratumumab?

Published:2024-06 Issue: Volume:25 Page:100410
ISSN:2772-3682
Container-title:The Lancet Regional Health - Southeast Asia
language:en
Short-container-title:The Lancet Regional Health - Southeast Asia

Author:

Berentsen Sigbjørn^ORCID,Datta Suvro Sankha^ORCID

Publisher

Elsevier BV

Reference8 articles.

1. Time for newer approach in age-old AIHA;Mehta;Lancet Reg Health Southeast Asia,2024

2. Management of autoimmune haemolytic anaemia in low-to-middle income countries: current challenges and the way forward;Datta;Lancet Reg Health Southeast Asia,2023

3. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation;Schuetz;Blood Adv,2018

4. Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy;Tomkins;Am J Hematol,2020

5. The immunomodulatory effect and clinical efficacy of daratumumab in a patient with cold agglutinin disease;Zaninoni;Front Immunol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP